Cyclophosphamide and cancer: golden anniversary

By A. Emadi, Richard J. Jones, R. Brodsky. Nature Reviews Clinical Oncology, 2009

931 citations recorded by the source corpus.

Subfields: Hematology, Immunology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/12d3f225294429615b35bbdf826f1b53fd23a5fd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Salomone
2. L. Falzone
3. M. Libra

Citations in the corpus

• Mechanisms of DNA damage, repair and mutagenesis (2017, neutral): “3B) used in the treatment of lymphomas, leukemias and solid tumors [Emadi et al., 2009].”
• Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium (2018, background): “It is used in the treatment of lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, nonsmall cell lung carcinoma (NSCLC), neuroblastoma, sarcoma, as well as in the treatment of several autoimmune diseases (Emadi et al., 2009; Brummaier et al., 2013; Kim and Chan, 2017).”